title: Role of obesity on the efficacy of exemestane plus ovarian suppression in hormone receptor-positive premenopausal breast cancer.
authors.affiliation: Department of Medical Oncology, Faculty of Medicine, Yıldırım Beyazıt University, 06100 Sihhiye, Ankara, Turkey.
authors.forename: Mehmet Ali Nahit
authors.initials: MA
authors.lastname: Şendur
authors.forename: Sercan
authors.initials: S
authors.lastname: Aksoy
authors.forename: Muhammed Bülent
authors.initials: MB
authors.lastname: Akıncı
authors.forename: Nuriye
authors.initials: N
authors.lastname: Ozdemir
authors.forename: Didem Şener
authors.initials: DŞ
authors.lastname: Dede
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
authors.forename: Nurullah
authors.initials: N
authors.lastname: Zengin
authors.forename: Bülent
authors.initials: B
authors.lastname: Yalçın
mesh_terms: D000730:Androstadienes / Q000494:pharmacology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000150:complications* / Q000188:drug therapy* / Q000378:metabolism / Q000401:mortality; D005260:Female; D006801:Humans; D009765:Obesity / Q000150:complications*; D010053:Ovary / Q000187:drug effects / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D000730:Androstadienes; D000970:Antineoplastic Agents; D047072:Aromatase Inhibitors; D011960:Receptors, Estrogen; C056516:exemestane
keywords: aromatase inhibitors; exemestane; ovarian suppression; premenopausal breast cancer; tamoxifen